Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$33,402,992
-$2,385,854 QoQ
Shares Held
919,686
+19.6% QoQ
Ownership
0.872%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 97.26547973982424.ToString("F0")%
Shared 0.ToString("F0")%
None 2.7345202601757554.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. CRNX ranks #66 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CRNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $33,402,992 | 919,686 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $35,788,846 | 768,826 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $28,410,879 | 682,134 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $21,858,229 | 760,022 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $17,262,498 | 514,684 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $25,822,691 | 505,040 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $34,012,104 | 665,599 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $37,562,007 | 838,625 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $28,657,079 | 612,200 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $23,064,767 | 648,251 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $15,206,683 | 511,321 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $13,445,780 | 746,159 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,485,827 | 652,916 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,792,357 | 152,588 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,003,905 | 102,032 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,603,834 | 139,616 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $2,091,611 | 95,290 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,078,952 | 37,978 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,451,480 | 68,954 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,430,641 | 181,997 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,067,504 | 200,753 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,620,818 | 185,742 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $637,862 | 40,706 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,746,142 | 213,821 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $33,088 | 2,251 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||